Last update 07 Jun 2025

LASSBio-1945

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LASSBio-1945
Target
SARS-CoV-2 Mpro
Action
inhibitors
Mechanism
SARS-CoV-2 Mpro inhibitors(SARS-CoV-2 main protease inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
COVID-19
Originator Organization
Federal University of Rio de JaneiroFederal University of Rio de Janeiro
Active Organization-
Inactive Organization
Federal University of Rio de JaneiroFederal University of Rio de Janeiro
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC20H24N2O4S
InChIKeyRTNFALLGIDGVDR-UHFFFAOYSA-N
CAS Registry2765427-01-6

Related

100 Clinical Results associated with LASSBio-1945
Login to view more data
100 Translational Medicine associated with LASSBio-1945
Login to view more data
100 Patents (Medical) associated with LASSBio-1945
Login to view more data
1
Literatures (Medical) associated with LASSBio-1945
RSC medicinal chemistryQ4 · MEDICINE
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore model
Q4 · MEDICINE
100 Deals associated with LASSBio-1945
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Preclinical
Brazil
Federal University of Rio de JaneiroFederal University of Rio de Janeiro
01 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free